Are Benzodiazepines the New Opioids?
Yale addiction specialists believe the primary care system can play a key role in preventing another medication epidemic. David A. Fiellin, MD, worries that otherwise, the trajectory of benzodiazepine prescriptions might lead to a situation that resembles the opioid crisis.
Yale Investigators' Lead Grant Awarded as Part of the NIH HEAL Initiative on Opioids
Dr. Gail D’Onofrio, Professor of Emergency Medicine and Public Health and Dr. David Fiellin, Professor of Medicine, Emergency Medicine and Public Health are lead investigators in a $25.5 Million study being conducted by the National Drug Abuse Treatment Clinical Trials Network’s New England Consortium Node.
Yale Researchers Awarded Grant to Study Smoking Treatment in People With HIV
Drs. E. Jennifer Edelman and Steven L. Bernstein received a grant award to address tobacco smoking addiction among people with HIV. The National Cancer Institute grant, totaling more than $3 million, supports a five-year research project.
More Vaping-Related Dangers?
According to a recent Yale study, inhaling vapor from flavored e-cigarette liquid exposes users to previously undetected chemical byproducts called acetals. As a result of the study, the authors hope the FDA will begin to study the short- and long-term effects of inhaled acetals.
$5.5 Million Grant Supports Study of Model to Integrate Treatments for Opioid Addiction, Infectious Diseases
As part of a multi-site collaboration involving principal investigators from Columbia University, Medical University of South Carolina (MUSC), and University of South Carolina School of Medicine-Greenville, Yale’s Dr. Sandra Springer will study a new model of treatment for opioid addiction. The investigation is supported by a grant from the National Center for Advancing Translational Sciences.
Yale and Mayo Clinic Awarded FDA Grant to Study Opioid Prescribing and Use
Yale University and Mayo Clinic have been awarded a grant for up to $5.3 million over two years by the U.S. Food and Drug Administration (FDA) to study patients’ experiences with pain and use of opioids prescribed for acute pain. This project is part of the Center of Excellence in Regulatory Science and Innovation (CERSI), a joint effort between Yale, Mayo Clinic, and the FDA. The study will be conducted in collaboration with Regional Health of Rapid City, S.D., and University of Alabama at Birmingham (UAB).
Yale Expert Delivers Talk at White House on Role of Addiction Specialists in Hospitals
On June 25, Yale School of Medicine’s Dr. Jeanette Tetrault spoke at a convening of the President’s Opioid Commission and the Office of National Drug Control Policy. The purpose of the meeting was to discuss the steps needed to build a national addiction medicine workforce and give Americans access to the care they need. Her talk, which focused on the role of addiction medicine specialists in emergency departments (EDs), was part of a congressional briefing sponsored by the American College of Academic Addiction Medicine.
Chen and Team Win Award from 2019 NIDA $100K SUD Startup Challenge
Kevin Chen, MD, fellow, National Clinical Scholars Program, and his team recently won an award as part of the 2019 NIDA $100K SUD Startup Challenge. Sponsored by the National Institute on Drug Abuse, the award is given to 10 winners for their startup projects to improve the well-being of those with substance use disorders.
Implementation Science: Putting Important Discoveries to Their Best Use
Scientific innovations are created every day, but how do we ensure that they are used efficiently and reach the people who need them most? David Chambers, DPhil, deputy director for implementation science in the Division of Cancer Control & Population Sciences at the National Cancer Institute, tackled that question during his June 25 grand rounds lecture titled “Advancing the Science of Implementation in Cancer Control: An NCI Perspective."
Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.